Genzyme, Sanofi's Cancer Drug Patent Ruled Valid
A Delaware federal judge on Wednesday upheld a Genzyme Corp. patent for the cancer treatment drug Mobozil in Genzyme and Sanofi-Aventis U.S. LLC's suit over Teva Pharmaceuticals USA Inc. and Dr....To view the full article, register now.
Already a subscriber? Click here to view full article